Latest Market Strategy News

Appen Limited reported a 9.2% revenue decline to $103.2 million for H1 2025, offset by robust 67% growth in its China business unit. Despite increased net losses, the company maintains a strong cash position and focuses on generative AI expansion and operational efficiency.

Trajan Group Holdings has reported record FY25 revenue of $166.5 million, beating guidance and setting a solid foundation for FY26 with continued organic growth and improved profitability.

Alcidion Group Limited has reported a transformative FY25 with record earnings, a major NHS contract win, and a robust outlook for FY26. The company’s healthcare technology platform is gaining traction across the UK and Australia, setting the stage for accelerated growth.

WiseTech Global posted robust FY25 results with 14% revenue growth and a 53% EBITDA margin excluding acquisition costs, while finalising the strategic e2open acquisition to broaden its global logistics software footprint.

ReadyTech reported a solid 7.1% revenue increase in FY25, driven by $15.4 million in new enterprise contracts and a strategic push into AI-enhanced SaaS products. The company’s strong pipeline and AI initiatives set the stage for accelerated growth in FY26 and beyond.

CleanSpace Holdings posted a robust 26% revenue increase in FY25, turning the corner to positive EBITDA and cash flow in the second half, driven by strong industrial market demand and operational efficiencies.

CleanSpace Holdings Limited reported a 26% increase in revenue to $19.8 million for FY25, alongside a significant reduction in net loss to $478,276. The company’s strategic expansion and innovation efforts underpin its improving financial health and global market presence.

Decidr AI Industries has agreed to acquire the remaining 49% stake in Decidr.ai, issuing 78.4 million shares to complete full ownership and accelerate its AI platform integration.

Aussie Broadband has reported robust FY25 results with strong revenue and EBITDA growth, boosted by strategic contracts and operational efficiencies. The company sets an ambitious FY26 EBITDA target amid ongoing market expansion.

Navigator Global Investments has delivered a record financial performance in FY25, with Adjusted EBITDA rising 26% and net profit after tax soaring 80%, underpinned by strong asset growth and strategic board changes.

Vita Life Sciences delivered a robust first half in 2025 with record revenue and profit growth, driven by strong performances in Australia and Southeast Asia. The company also raised its interim dividend and expanded marketing efforts.

EOS has reported a 126% increase in its contract backlog to $307 million in 1H 2025, driven by strong demand for its defence and space technologies despite a revenue decline. The company secured a landmark €71.4 million high energy laser weapon export contract and continues to strengthen its balance sheet.